![](/img/cover-not-exists.png)
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy
Dr J. S. Whelan, C. L. Davis, A. Z. S. Rohatiner, M. Leahy, P. K. Maccallum, R. K. Gupta, J. Matthews, A. J. Norton, J. A. L. Amess, T. A. ListerVolume:
10
Year:
1992
Language:
english
Pages:
8
DOI:
10.1002/hon.2900100204
File:
PDF, 510 KB
english, 1992